Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134729) titled 'Efficacy of Immunotherapy Combined with HAIC-FOLFOX as Neoadjuvant Therapy for Gallbladder Carcinoma with High Recurrence Risk: A Prospective, Single-Center, Phase II Clinical Study' on Oct. 20.
Study Type: Interventional study
Study Design:
Single arm
Primary Sponsor: Cancer Hospital of Shandong First Medical University(Shandong Cancer Institute, Shandong Cancer Hospital)
Condition:
Biliary Tract Cancer
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-11-15
Target Sample Size: Experimental group:50;
Countries of Recruitment:
China
To know more, visit https://www.chictr.o...